A citation-based method for searching scientific literature

Ryosuke Amemiya, Tomohiro Miyoshi, Keiju Aokage, Jun Suzuki, Hironobu Hoshino, Hibiki Udagawa, Kenta Tane, Masato Sugano, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Koichi Goto, Norihiko Ikeda, Masahiro Tsuboi, Genichiro Ishii. Lung Cancer 2021
Times Cited: 4







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report.
Yoko Matsumoto, Tamaki Miura, Hajime Horiuchi, Kazuhiro Usui. Case Rep Oncol 2017
26
75

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
50

Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Sehui Kim, Moon-Young Kim, Jaemoon Koh, Heounjeong Go, Dong Soo Lee, Yoon Kyung Jeon, Doo Hyun Chung. Eur J Cancer 2015
121
50

Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Hyun-Mi Bae, Hye Sook Min, Se-Hoon Lee, Dong-Wan Kim, Doo Hyun Chung, Jong-Seok Lee, Young Whan Kim, Dae Seog Heo. Lung Cancer 2007
109
50

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Matthew D Hellmann, Luis Paz-Ares, Reyes Bernabe Caro, Bogdan Zurawski, Sang-We Kim, Enric Carcereny Costa, Keunchil Park, Aurelia Alexandru, Lorena Lupinacci, Emmanuel de la Mora Jimenez,[...]. N Engl J Med 2019
25

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.
Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A Sinicrope. Cancer Discov 2020
150
25

Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Dapeng Li, Yihebali Chi, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng,[...]. Clin Cancer Res 2021
19
25

"Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy.
Kentaro Ito, Osamu Hataji, Koji Katsuta, Tetsu Kobayashi, Esteban C Gabazza, Yasushi Yatabe, Osamu Taguchi, Nobuyuki Yamamoto. J Thorac Oncol 2016
24
25



Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.
Ping Chen, Min Yu, Ji-Liang Zhang, Wei-Yong Chen, Li Zhu, Yue Song, Cheng-Yi Jiang, Shuang Zhang. World J Clin Cases 2020
4
25

Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.
Hirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, Noritaka Honda, Takayuki Suyama, Yasuhiro Umeyama, Yosuke Dotsu, Takumi Nakao, Kojima Tomohito, Hiroshi Gyotoku,[...]. Thorac Cancer 2021
5
25

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer.
Jiewei Chen, Qingmei He, Jun Liu, Yongbo Xiao, Canhua Xiao, Keming Chen, Dan Xie, Xinke Zhang. Cancer Manag Res 2018
22
25

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Yizhuo Zhao,[...]. JAMA Oncol 2018
256
25

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.
Xuewen Liu, Yuxia Jia, Mark B Stoopler, Yufeng Shen, Haiying Cheng, Jinli Chen, Mahesh Mansukhani, Sanjay Koul, Balazs Halmos, Alain C Borczuk. J Clin Oncol 2016
224
25

6
25

A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer.
Di Wu, Jun Nie, Weiheng Hu, Ling Dai, Jie Zhang, Xiaoling Chen, Xiangjuan Ma, Guangming Tian, Jindi Han, Sen Han,[...]. Int J Cancer 2020
18
25

Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report.
Akihiro Yoshimura, Chieko Takumi, Taisuke Tsuji, Ryosuke Hamashima, Shinsuke Shiotsu, Tatsuya Yuba, Yoji Urata, Noriya Hiraoka. Clin Case Rep 2018
7
25

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
Charlotte Domblides, Karen Leroy, Isabelle Monnet, Julien Mazières, Fabrice Barlesi, Valérie Gounant, Simon Baldacci, Bertrand Mennecier, Anne-Claire Toffart, Clarisse Audigier-Valette,[...]. J Thorac Oncol 2020
47
25

MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy.
Selina K Wong, Deepu Alex, Ian Bosdet, Curtis Hughesman, Aly Karsan, Stephen Yip, Cheryl Ho. Lung Cancer 2021
5
25

Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma.
Yongbin Lin, Han Yang, Qingqing Cai, Daofeng Wang, Huilan Rao, Suxia Lin, Hao Long, Jianhua Fu, Lanjun Zhang, Peng Lin,[...]. Am J Clin Oncol 2016
60
25

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.
Miso Kim, Bhumsuk Keam, Chan-Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin-Soo Kim, Tae Min Kim, Sook-Hee Hong, Mi Sun Ahn,[...]. Thorac Cancer 2020
7
25


Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Jin Li, Shukui Qin, Jianming Xu, Weijian Guo, Jianping Xiong, Yuxian Bai, Guoping Sun, Yan Yang, Liwei Wang, Nong Xu,[...]. J Clin Oncol 2013
385
25

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report.
Eriko Fujimoto, Takashi Yokoi, Koji Mikami, Shingo Kanemura, Eisuke Shibata, Daisuke Horio, Yuichi Koda, Yoshiki Negi, Yumiko Akano, Akio Tada,[...]. Case Rep Oncol 2018
8
25

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
Thibault Vieira, Martine Antoine, Cécile Hamard, Vincent Fallet, Michael Duruisseaux, Nathalie Rabbe, Anita Rodenas, Jacques Cadranel, Marie Wislez. Lung Cancer 2016
88
25


Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis.
Massimiliano Salati, Cinzia Baldessari, Fiorella Calabrese, Giulio Rossi, Elisa Pettorelli, Giulia Grizzi, Massimo Dominici, Fausto Barbieri. Case Rep Oncol 2018
22
25


Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, James Suh, Eduardo Braun, Ranee Mehra, Steven C Buck, Jose A Bufill, Nir Peled, Nagla Abdel Karim,[...]. J Thorac Oncol 2017
94
25

Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.
E Giroux Leprieur, M Antoine, T Vieira, M Duruisseaux, V Poulot, N Rabbe, L Belmont, V Gounant, A Lavolé, B Milleron,[...]. Lung Cancer 2013
22
25

Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.
Osamu Honjo, Terufumi Kubo, Fumiko Sugaya, Takahiro Nishizaka, Koji Kato, Yoshihiko Hirohashi, Hiroki Takahashi, Toshihiko Torigoe. J Immunother Cancer 2019
33
25

Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.
Takafumi Yorozuya, Tetsuya Taya, Kento Yasuda, Yutaro Nagano, Makoto Shioya, Hirofumi Chiba, Hiroki Takahashi. Thorac Cancer 2020
7
25


Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung.
Thibault Vieira, Martine Antoine, Anne-Marie Ruppert, Vincent Fallet, Michael Duruisseaux, Etienne Giroux Leprieur, Virginie Poulot, Nathalie Rabbe, Laurene Sclick, Michele Beau-Faller,[...]. Lung Cancer 2014
51
25

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, Harry J M Groen, Daniel S W Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov,[...]. N Engl J Med 2020
287
25

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.
Jae Kyeom Sim, Sang Mi Chung, Jong Hyun Choi, Jee Youn Oh, Seung Heon Lee, Je Hyeong Kim, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang,[...]. Korean J Intern Med 2018
17
25

Impressive response to nivolumab of non-small-cell lung cancer containing sarcomatoid components.
Takahiro Ota, Seiji Niho, Keisuke Kirita, Genichiro Ishii, Masahiro Tsuboi, Koichi Goto. Respirol Case Rep 2019
6
25

Recent advances in the management of pulmonary sarcomatoid carcinoma.
Elaine Shum, Matthew Stuart, Alain Borczuk, Feng Wang, Haiying Cheng, Balazs Halmos. Expert Rev Respir Med 2016
16
25

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.
Kazuaki Okamura, Yuichi Fukuda, Hiroshi Soda, Daiki Ogawara, Keisuke Iwasaki, Shinichiro Fuchi, Takayuki Suyama, Masataka Yoshida, Tatsuhiko Harada, Minoru Fukuda,[...]. Thorac Cancer 2018
13
25

The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.
Xiangli Jiang, Yanxue Liu, Cheng Chen, Zhongli Zhan, Qingna Yan, Yuhong Guo, Qingsheng Wang, Kai Li. Clin Lung Cancer 2012
37
25

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
Kazumi Nishino, Kei Kunimasa, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Toru Kumagai. BMC Pharmacol Toxicol 2020
5
25

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Paul K Paik, Enriqueta Felip, Remi Veillon, Hiroshi Sakai, Alexis B Cortot, Marina C Garassino, Julien Mazieres, Santiago Viteri, Helene Senellart, Jan Van Meerbeeck,[...]. N Engl J Med 2020
261
25

Concurrent combination of irradiation and immune checkpoint inhibitor for recurrent pleomorphic carcinoma of the lung.
Ken Kodama, Tomohiro Maniwa, Yukio Kimura, Yuriko Yagi, Yoko Yamamoto, Toshika Ohkawa, Masashi Takeda, Hiroki Kishima, Genju Koh, Takamasa Toyofuku. Int Cancer Conf J 2017
7
25

Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review.
Xiaofeng Li, Yueming He, Jinfeng Zhu, Hongxia Pang, Yongwei Lin, Jinyang Zheng. Oncotarget 2018
8
25


Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post-surgical recurrence.
Daizo Yaguchi, Motoshi Ichikawa, Masao Ito, Sawako Okamoto, Hayata Kimura, Kazuko Watanabe. Thorac Cancer 2019
20
25

Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
Xuewen Liu, Fang Wang, Chunwei Xu, Xinru Chen, Xue Hou, Qian Li, Pansong Li, Zhi Xie, Yongdong Liu, Lianpeng Chang,[...]. Oncogene 2021
10
25

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.
Mitra Mehrad, Somak Roy, William A LaFramboise, Patti Petrosko, Caitlyn Miller, Pimpin Incharoen, Sanja Dacic. Histopathology 2018
25
25

Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy.
Sheera R Rosenbaum, Nicole A Wilski, Andrew E Aplin. Cancer Discov 2021
40
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.